Eli Lilly’s experimental obesity pill, orforglipron, met its main goals in a closely watched late-stage trial, boosting the company’s standing in the fast-growing market for weight loss and diabetes ...

The health secretary said he would prioritize studies into environmental causes while harshly discounting other factors ...

For generations, the pot belly in India has been more than just a physical attribute ~ it has been a symbol.

During Abu Dhabi Global Health Week (ADGHW), the Abu Dhabi Public Health Centre (ADPHC) and the McKinsey Health Institute of ...

Nasdaq pressured by tech losses, S&P 500 vulnerable. Google faces DOJ breakup risk, while traders brace for Netflix earnings ...

Too often, young people in the U.S. just on the threshold of adulthood face cardiovascular challenges. By the time they're 18 ...

The Zacks Medical - Products industry is likely to face rising uncertainty amid tariff imposition by the United ...

As well as eggs costing over €20, and some as high as €50, shoppers also face shrinkflation as manufacturers reduce egg sizes ...

Kevin Hall said his work on ultraprocessed foods has been “hobbled” under the Trump administration. Scientists have been ...

The first GLP-1 pill could be in medicine cabinets sooner than expected. Eli Lilly (LLY) announced Thursday that its daily ...

It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (NYSE: LLY) stock is off to the races! This morning, the ...

By the time they're 18, many teenagers will have heart disease risk factors such as obesity, high cholesterol, high blood ...